Barcelona, Spain

Marta Guerrero




Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Marta Guerrero: Innovator in Cardiovascular and Sleep Apnea Treatments

Introduction

Marta Guerrero is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the fields of cardiovascular health and sleep medicine. With a total of three patents to her name, her work focuses on innovative solutions for high-risk populations.

Latest Patents

One of her latest patents is a capsule designed for the prevention of cardiovascular diseases. This invention comprises coated tablets of acetylsalicylic acid, simvastatin or pravastatin, and lisinopril, ramipril, or perindopril. The capsules are specifically formulated for use in high-risk populations to prevent cardiovascular diseases. Another notable patent is for a monohydrochloride salt of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine. This method provides treatment for sleep apnea and other related conditions by administering an effective amount of crystalline monohydrochloride to patients in need.

Career Highlights

Marta Guerrero has worked with reputable companies such as Bioprojet and Ferrer Internacional, S.A. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to her success as an inventor.

Collaborations

Throughout her career, Marta has collaborated with notable individuals, including Manuel M Raga and Juan Sallares. These partnerships have further enhanced her research and development efforts.

Conclusion

Marta Guerrero is a trailblazer in the fields of cardiovascular and sleep medicine, with her patents reflecting her commitment to improving health outcomes. Her innovative work continues to make a significant impact in these critical areas.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…